Clinical Outcome Event Adjudication in a 10-Year Prospective Study of Nucleos(t)ide Analogue Therapy for Chronic Hepatitis B

Background and Aims: In the REALM (Randomized, Observational Study of Entecavir to Assess Long-Term Outcomes Associated with Nucleoside/Nucleotide Monotherapy for Patients with Chronic HBV Infection) study, 12,378 patients with chronic hepatitis B virus (HBV) infection received up to 10 years of ran...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Joseph K, Chang, Alex Y, Zaman, Atif, Martin, Paul, Fernandez-Rodriguez, Conrado M, Korkmaz, Mete, Rossi, Simona, Ford, James M, Noonan, Tamara, Cooney, Elizabeth, Navarro, Victor, Colombato, Luis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: XIA & HE Publishing Inc. 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7782110/
https://www.ncbi.nlm.nih.gov/pubmed/33447520
http://dx.doi.org/10.14218/JCTH.2020.00039

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7782110/
https://www.ncbi.nlm.nih.gov/pubmed/33447520
http://dx.doi.org/10.14218/JCTH.2020.00039

Ejemplares similares